Protein FDR Confidence: CombinedAccessionDescriptionExp. q-value: CombinedSum PEP ScoreCoverage [%]# Peptides# PSMs# Unique Peptides# AAsMW [kDa]calc. pIAbundance Ratio: (DKO) / (WT)Abundance Ratio: (SKO) / (WT)Abundance Ratio (log2): (DKO) / (WT)Abundance Ratio (log2): (SKO) / (WT)Abundance Ratio P-Value: (DKO) / (WT)Abundance Ratio P-Value: (SKO) / (WT)Abundance Ratio Adj. P-Value: (DKO) / (WT)Abundance Ratio Adj. P-Value: (SKO) / (WT)Abundances (Grouped): DKOAbundances (Grouped): SKOAbundances (Grouped): WTAbundances (Grouped) CV [%]: DKOAbundances (Grouped) CV [%]: SKOAbundances (Grouped) CV [%]: WTAbundances (Scaled): F1: 127C, Sample, DKO, 1Abundances (Scaled): F1: 128C, Sample, DKO, 2Abundances (Scaled): F1: 129C, Sample, DKO, 3Abundances (Scaled): F1: 130C, Sample, DKO, 4Abundances (Scaled): F1: 129N, Sample, SKO, 1Abundances (Scaled): F1: 130N, Sample, SKO, 2Abundances (Scaled): F1: 131, Sample, SKO, 3Abundances (Scaled): F1: 126, Sample, WT, 1Abundances (Scaled): F1: 127N, Sample, WT, 2Abundances (Scaled): F1: 128N, Sample, WT, 3Abundances (Normalized): F1: 127C, Sample, DKO, 1Abundances (Normalized): F1: 128C, Sample, DKO, 2Abundances (Normalized): F1: 129C, Sample, DKO, 3Abundances (Normalized): F1: 130C, Sample, DKO, 4Abundances (Normalized): F1: 129N, Sample, SKO, 1Abundances (Normalized): F1: 130N, Sample, SKO, 2Abundances (Normalized): F1: 131, Sample, SKO, 3Abundances (Normalized): F1: 126, Sample, WT, 1Abundances (Normalized): F1: 127N, Sample, WT, 2Abundances (Normalized): F1: 128N, Sample, WT, 3Abundance: F1: 127C, Sample, DKO, 1Abundance: F1: 128C, Sample, DKO, 2Abundance: F1: 129C, Sample, DKO, 3Abundance: F1: 130C, Sample, DKO, 4Abundance: F1: 129N, Sample, SKO, 1Abundance: F1: 130N, Sample, SKO, 2Abundance: F1: 131, Sample, SKO, 3Abundance: F1: 126, Sample, WT, 1Abundance: F1: 127N, Sample, WT, 2Abundance: F1: 128N, Sample, WT, 3Abundances Count: F1: 127C, Sample, DKO, 1Abundances Count: F1: 128C, Sample, DKO, 2Abundances Count: F1: 129C, Sample, DKO, 3Abundances Count: F1: 130C, Sample, DKO, 4Abundances Count: F1: 129N, Sample, SKO, 1Abundances Count: F1: 130N, Sample, SKO, 2Abundances Count: F1: 131, Sample, SKO, 3Abundances Count: F1: 126, Sample, WT, 1Abundances Count: F1: 127N, Sample, WT, 2Abundances Count: F1: 128N, Sample, WT, 3Biological ProcessCellular ComponentMolecular FunctionPfam IDsEntrez Gene IDGene SymbolChromosomeReactome PathwaysEnsembl Gene IDKEGG PathwaysWikiPathways# Razor PeptidesModifications
HighQ61016Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 OS=Mus musculus OX=10090 GN=Gng7 PE=1 SV=2025.84247262687.58.510.430.76-1.22-0.40.2271007010.2554100480.9367768020.9028326958.9104.113710.5719.1815.758.963.172.157.381107.8119.5126.5171.8141.9128.6137.7157.4125176.8235.2260.7275.9374.8309.6100.1118.6140.2108.1165.1191.6260.7252.2330.3285.63333333333defense response;regulation of biological process;response to stimulusmembranesignal transducer activityPf0063114708Gng710"Glucagon signaling in metabolic regulation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Adrenaline,noradrenaline inhibits insulin secretion; Activation of G protein gated Potassium channels; Vasopressin regulates renal water homeostasis via Aquaporins; Glucagon-type ligand receptors; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits"ENSMUSG00000048240.14Morphine addiction; Cholinergic synapse; Retrograde endocannabinoid signaling; Dopaminergic synapse; Ras signaling pathway; GABAergic synapse; Chemokine signaling pathway; Glutamatergic synapse; Pathways in cancer; Alcoholism; PI3K-Akt signaling pathway; Olfactory transduction; Circadian entrainment; Serotonergic synapseChemokine signaling pathway; G Protein Signaling Pathways; Focal Adhesion-PI3K-Akt-mTOR-signaling pathway; Myometrial Relaxation and Contraction Pathways; Calcium Regulation in the Cardiac Cell0

[View entry in the full dataset]